Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program.
The company also raised its full-year sales and adjusted earnings guidance
Chief Executive Officer Fred Lowery said the company’s second-quarter performance reflected sustained momentum across its businesses, strong gross margins and operational execution. He said Henry Schein is focused on accelerating growth, simplifying its operations, strengthening customer relationships and improving profitability. “Our first half performance and the sustained momentum have positioned us to raise our full year 2026 guidance,” Lowery said. Second-Quarter Financial Results Global sales totaled $3.5 billion in the second quarter, up 6.7% from the prior-year period.
The increase included 4.6% internal local-currency sales growth, a 1.4% benefit from foreign exchange and 0.7% growth from acquisitions, according to Senior Vice President and Chief Financial Officer Ron South. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million, or $0.70 per diluted share, a year earlier. On a non-GAAP basis, net income was $145 million, or $1.27 per diluted share, compared with $135 million, or $1.10 per diluted share, in the second quarter of 2025.